HomeCompareSCPH vs ADC

SCPH vs ADC: Dividend Comparison 2026

SCPH yields 35.27% · ADC yields 4.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ADC wins by $340.00 in total portfolio value· pulled ahead in Year 10
10 years
SCPH
SCPH
● Live price
35.27%
Share price
$5.67
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$178.6K
Annual income
$27,157.20
Full SCPH calculator →
ADC
Agree Realty Corporation
● Live price
4.13%
Share price
$74.97
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$178.9K
Annual income
$80,797.29
Full ADC calculator →

Portfolio growth — SCPH vs ADC

📍 ADC pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSCPHADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SCPH + ADC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SCPH pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCPH
Annual income on $10K today (after 15% tax)
$2,998.24/yr
After 10yr DRIP, annual income (after tax)
$23,083.62/yr
ADC
Annual income on $10K today (after 15% tax)
$351.36/yr
After 10yr DRIP, annual income (after tax)
$68,677.70/yr
At 15% tax rate, ADC beats the other by $45,594.08/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCPH + ADC for your $10,000?

SCPH: 50%ADC: 50%
100% ADC50/50100% SCPH
Portfolio after 10yr
$178.8K
Annual income
$53,977.25/yr
Blended yield
30.19%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

SCPH
Analyst Ratings
5
Buy
3
Hold
Consensus: Buy
Price Target
$8.12
+43.2% upside vs current
Range: $5.35 — $13.00
Altman Z
-7.3
Piotroski
2/9
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+8.1% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCPH buys
0
ADC buys
0
No recent congressional trades found for SCPH or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSCPHADC
Forward yield35.27%4.13%
Annual dividend / share$2.00$3.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$178.6K$178.9K
Annual income after 10y$27,157.20$80,797.29
Total dividends collected$129.2K$156.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusBuyBuy
Analyst price target$8.12$81.06

Year-by-year: SCPH vs ADC ($10,000, DRIP)

YearSCPH PortfolioSCPH Income/yrADC PortfolioADC Income/yrGap
1$14,227$3,527.34$10,990$580.36+$3.2KSCPH
2$19,913$4,690.15$12,301$860.26+$7.6KSCPH
3$27,442$6,135.14$14,104$1,298.62+$13.3KSCPH
4$37,265$7,901.67$16,691$2,008.16+$20.6KSCPH
5$49,902$10,028.00$20,580$3,205.09+$29.3KSCPH
6$65,945$12,549.99$26,754$5,330.02+$39.2KSCPH
7$86,061$15,499.75$37,196$9,345.14+$48.9KSCPH
8$110,989$18,904.51$56,244$17,523.09+$54.7KSCPH
9$141,544$22,785.49$94,286$35,736.21+$47.3KSCPH
10← crossover$178,609$27,157.20$178,949$80,797.29$340.00ADC

SCPH vs ADC: Complete Analysis 2026

SCPHStock

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts.

Full SCPH Calculator →

ADCREIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this SCPH vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCPH vs SCHDSCPH vs JEPISCPH vs OSCPH vs KOSCPH vs MAINSCPH vs NNNSCPH vs EPRTSCPH vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.